Epidemiology and issues of NIV ‐treated AECOPD patients with hypercapnic respiratory failure in Shanghai: A multicentre retrospective survey
ConclusionThe NIV can be successfully used for AECOP patients in local hospitals of Shanghai, but accompanied by high costs and long hospital stays. However, the treatments for exacerbation and stable COPD patients are still insufficient.
Source: The Clinical Respiratory Journal - Category: Respiratory Medicine Authors: Sheng ‐mei Wang,
Feng‐ying Zhang,
Chun‐ling Du,
Xiong‐biao Wang,
Fan Li,
Jing‐qing Hang,
Yuan‐jing Chen,
Ke‐wen Cheng,
Lei Zhao,
Xiao‐yan Jin,
Jin‐dong Shi,
Zhi‐jun Jie,
Jie‐ming Qu,
Shanghai Primary Respiratory Care Uni Tags: ORIGINAL ARTICLE Source Type: research
More News: Chronic Obstructive Pulmonary | Corticosteroid Therapy | Epidemiology | Intensive Care | Respiratory Medicine | Study